2020
DOI: 10.1016/j.htct.2020.04.001
|View full text |Cite
|
Sign up to set email alerts
|

COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 7 publications
0
8
0
2
Order By: Relevance
“…Infectious diseases are not uncommon in hematology patients, especially among HSCT recipients; nevertheless, the COVID-19 pandemic has considerably changed the practices of hematologists worldwide. While rapidly and efficiently treating the patients remains the optimal goal, repeated pre-admission PCR testing, reinforced isolation, use of personal protective equipment, and have become a standard-of-care prior to any new hospitalization or aplasia- inducing treatment [7] .…”
Section: Discussionmentioning
confidence: 99%
“…Infectious diseases are not uncommon in hematology patients, especially among HSCT recipients; nevertheless, the COVID-19 pandemic has considerably changed the practices of hematologists worldwide. While rapidly and efficiently treating the patients remains the optimal goal, repeated pre-admission PCR testing, reinforced isolation, use of personal protective equipment, and have become a standard-of-care prior to any new hospitalization or aplasia- inducing treatment [7] .…”
Section: Discussionmentioning
confidence: 99%
“…4 In these patients, the probability of developing severe case of COVID-19 is higher than healthy individuals without comorbidities. 5 The latest evidence showed that the risk of COVID-19 infection in cancer patients was the same as that Asian J Oncol in the normal population; however, cancer patients seemed to get severe complications of COVID-19 infection especially if they have recently undergone cancer treatment. 6,7 To control the rapid spread of disease dissemination, public health measures are undertaken to decrease hospital visits and elective procedures.…”
Section: Introductionmentioning
confidence: 99%
“…4 In these patients, the probability of developing severe case of COVID-19 is higher than healthy individuals without comorbidities. 5 The latest evidence showed that the risk of COVID-19 infection in cancer patients was the same as that in the normal population; however, cancer patients seemed to get severe complications of COVID-19 infection especially if they have recently undergone cancer treatment. 6,7 To control the rapid spread of disease dissemination, public health measures are undertaken to decrease hospital visits and elective procedures.…”
Section: Introductionmentioning
confidence: 99%